NHS staff are not failing, they are being failed, by successive Conservative Governments. Please RT if you agree.

Rishi Sunak said today at #PMQs that rising NHS waiting lists is down to industrial action. Well how about the last 13 years of rising waiting lists?

The Consultants of Dorset hospital have written a letter to Steve Barclay They strike tomorrow This letter is incredible I challenge anyone to refute a single point in it Worth a read for you too Wes Streeting

Consultant pay has fallen by 35%, and we’re leaving the NHS in droves. Watch Tom Dolphin🏳️‍🌈 🏳️‍⚧️ explain why we’re on strike in England today 👇👇👇 #ConsultantStrike

Around 1 in 3 UK medical students plans to leave the NHS within 2 years of graduating says BMJ. Dr Latifa warns: “It is not too late to fix [this increasingly untenable situation], but the power to do so rests with the Government.” bma.org.uk/bma-media-cent…

We’re trying to get as many followers as Rishi Sunak so we can show the government just how many people are prepared to fight for the NHS and its staff. Please can you help by following us and retweeting this?

We proceed with the Brainstorming Session series. Next up is the session focusing on unmet needs and research ideas in Non-Small Cell Lung Cancer #NSCLC Dr. Antonio Calles 🫁🚭 Giuseppe Banna Alfredo Addeo MD Carles Escriu #MEDSIRBrainstormingSeries #LungCancer #ClinicalTrials #Innovation

Finally, we turn our focus to the Brainstorming Session on unmet needs and research ideas in Mesothelioma. Dr. Antonio Calles 🫁🚭 Giuseppe Banna Alfredo Addeo MD Carles Escriu #MEDSIRBrainstormingSeries #LungCancer #ClinicalTrials #Innovation

Concluding the first #LungCancer #MEDSIRBrainstormingSeries! We delved into recent advancements and strategic development. Excited to lead in advancing knowledge and collaboration for the global benefit of cancer patients Dr. Antonio Calles 🫁🚭 Giuseppe Banna Alfredo Addeo MD Carles Escriu #Innovation

🚨📝 A pragmatic guide for management of adverse events associated with lorlatinib Link here 👉lungcancerjournal.info/article/S0169-… #LCSM ALK Positive

Lung cancer in never-smokers represent the 5thleading cause of cancer-related mortality in the world. They are highly enriched for targetable oncogenic alterations, have low TMB, low rates of PD-L1 positivity, & lack mutational signatures. They occur almost exclusively as

Most cancer drugs granted accelerated approval did not demonstrate benefit in overall survival or quality of life within 5 years of accelerated approval. ja.ma/3J3zZMi #AACR24

Alectinib in Resected ALK-Positive Non–Small-Cell Lung Cancer | New England Journal of Medicine nejm.org/doi/full/10.10…

🚀 Just out in Annals of Oncology: ETOP IBCSG Partners Foundation's position statement on antibody-drug conjugates (ADC) in lung and breast cancer. Honored to be a part of it, diving into the current evidence & future directions for clinical ADC development annalsofoncology.org/article/S0923-…

Personal selection of 30 new (+ new-ish) ADCs that will be presented at #ASCO24 divided by payloads and targets. Notes: - Including "publication only" abstracts - Not including mainstream ADCs and/or combo - Not including trial in progress

This is huge step forward for frailty & geriatric assessment of our patients. I love the possibility to export the output as .pdf or .csv! Thanks ONCOassist® | The go-to oncology app SIOG Young SIOG Cancer and Aging Research Group (CARG) #GeriOnc ASCO GeriOncCoP Geriatric-Oncology

We’ll see how curves and TRAEs look, but in my opinion more evidence that we should be sprinting towards induction immunotherapy for patients w/ NSCLC treated with chemoradiation. Nitin Ohri @DrSteveMartin ascopubs.org/doi/abs/10.120…

Abstracts are your paper's first impression. A weak abstract can sink even the best research. I transformed my abstract game with this 6-step Nature formula (and you can, too)